References
- Bodmeier R. Tableting of coated pellets, review. Eur. J. Pharm. Biopharm. 1997; 43: 1–8
- Bodmeier R., Paeratakul O. The effect of curing on drug release and morphological properties of ethylcellulose pseudolatex‐coated beads. Drug Dev. Ind. Pharm. 1994; 20: 1517–1533
- Goodhart F. W., Harris M. R., Murphy K. S., Nesbitt R. U. An evaluation of aqueous film‐forming dispersions for controlled release. Pharm. Technol. 1984; 4: 64–71
- Yuen K. H., Deshmukh A. A., Newton J. M. Development and in‐vitro evaluation of a multi‐particulate sustained release theophylline formulation. Drug Dev. Ind. Pharm. 1993; 19: 855–874
- Harris M. R., Ghebre‐Sellasie I. J. W. McGinityAqeous polymeric coating for modified‐release pellets. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, . Mercel Dekker, Inc., New York 1997; 63–79
- Amighi K., Moes A. J. Influence of plasticizer concentration and storage conditions on the drug release rate from eudragit RS 30 D film coated sustained release theophylline tablets. Eur. J. Pharm. Biopharm. 1996; 42: 29–35
- Hutchings D., Kuzmak B., Sakr A. Processing considerations for an EC latex coating system: influence of curing time and temperature. Pharm. Res. 1994; 11: 1474–1478
- Williams R. O., III, Liu J. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate. Eur. J. Pharm. Biopharm. 2000; 49: 243–252
- Alvan G., Paintaud G., Eckernas S. A., Grahnen A. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect. Br. J. Clin. Pharmacol. 1992; 34: 47–52
- Castaneda‐Hernandez G., Caille G., Du Souich P. Influence of drug formulation on drug concentration‐effect relationship. Clin. Pharmacokinet. 1994; 26: 135–143
- Reynolds J. E.F., et al. Cardiovascular agents. Martindale, The Extra Pharmacopoeia31 Ed. Royal Pharmaceutical Society, London 1996; 836–837
- Lee S. H., Lee M. G., Kim N. D. Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments. J. Pharm. Biopharm. 1994; 22: 1–17
- Hamed E., Sakr A. Application of multiple response optimization technique to extended release formulations design. J. Control. Release 2001; 73: 329–338
- United States Pharmacopoeia. USP XXV. United States Pharmacopeial Convention, Inc., Rockville, MD 2002; 2082–2084
- Husson I., Leclerc B., Spenlehauer G., Veillard M., Couarraze G. Modelling of drug release from coated pellets with an insoluble polymeric membrane. J. Control. Release 1991; 17: 163–174
- Gunder W., Lippold B. H., Lippold B. C. Release of drugs from ethyl cellulose microcapsules (diffusion pellets) with pore formers and pore fusion. Eur. J. Pharm. Sci. 1995; 3: 203–214
- Frohoff‐Hulsnmann M. A., Schmitz A., Lippold B. C. Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methyl cellulose as coating material for diffusion pellets. I: drug release rates from coated pellets. Int. J. Pharm. 1999; 177: 69–82
- Lippold B. C., Gunder W., Lippold B. H. Drug release from diffusion pellets coated with aqueous ethyl cellulose dispersion aquacoat( ECD‐30 and 20% dibutyl sebacate as plasticizer: partition mechanism and pore diffusion. Eur. J. Pharm. Biopharm. 1999; 47: 27–32
- Schulze P., Kleinebudde P. A new multiparticulate delayed release system. Part I: dissolution properties and release mechanism. J. Control. Release 1997; 47: 181–189
- Hutchings D., Sakr A. Influence of pH and plasticizers on drug release from ethylcellulose pseudolatex coated pellets. J. Pharm. Sci. 1994; 83: 1386–1390
- Desai S. J., Simonelli A. P., Higuchi W. I. Investigation of factors influencing release of solid drug dispersed in inert matrices. J. Pharm. Sci. 1965; 54: 1459–1464